Investigación de la hormona paratiroidea en el hiperparatiroidismo primario no familiar

Referencias
1. Beyer T.D., Solorzano C.C., Starr F., et al: Parathyroidectomy outcomes according to operative approach. Am J Surg 193. 368-372.2007;
2. Sackett W.R., Barraclough B., Reeve T.S., et al: Worldwide trends in the surgical treatment of primary hyperparathyroidism in the era of minimally invasive parathyroidectomy. Arch Surg 137. 1055-1059.2002;
3. Lorenz K., Nguyen-Thanh P., Dralle H.: Unilateral open and minimally invasive procedures for primary hyperparathyroidism: a review of selective approaches. Langenbecks Arch Surg 385. 106-117.2000;
4. Udelsman R.: Six hundred fifty-six consecutive explorations for primary hyperparathyroidism. Ann Surg 235. 665-670.2002;
5. Irvin , III , IIIG.L., Solorzano C.C., Carneiro D.M.: Quick intraoperative parathyroid hormone assay: surgical adjunct to allow limited parathyroidectomy, improve success rate, and predict outcome. World J Surg 28. 1287-1292.2004;
6. Chen H., Mack E., Starling J.R.: A comprehensive evaluation of perioperative adjuncts during minimally invasive parathyroidectomy: which is most reliable?. Ann Surg 242. 375-380.2005;
7. Chen H., Pruhs Z., Starling J.R., et al: Intraoperative parathyroid hormone testing improves cure rates in patients undergoing minimally invasive parathyroidectomy. Surgery 138. 583-587.2005;
8. Inabnet , III , IIIW.B., Dakin G.F., Haber R.S., et al: Targeted parathyroidectomy in the era of intraoperative parathormone monitoring. World J Surg 26. 921-925.2002;
9. Irvin, III, IIIG.L., Prudhomme D.L., Deriso G.T., et al: A new approach to parathyroidectomy. Ann Surg 219. 574-579.1994;
10. Irvin, III , IIIG.L., Carneiro D.M.: Management changes in primary hyperparathyroidism. JAMA 284. 934-936.2000;
11. Twigt B.A., Vollebregt A.M., van Dalen T., et al: Shifting incidence of solitary adenomas in the era of minimally invasive parathyroidectomy. A multi-institutional studyAnn Surg Oncol 18. 1041-1046.2011;
12. Smit P.C., Borel Rinkes I.H., van Dalen A., et al: Direct, minimally invasive adenomectomy for primary hyperparathyroidism: an alternative to conventional neck exploration?. Ann Surg 231. 559-565.2000;
13. Smit P.C., Thijssen J.H., Borel Rinkes I.H., et al: [Peroperative parathyroid hormone assay: assurance of successful surgical treatment of primary hyperparathyroidism]. Ned Tijdschr Geneeskd 143. 742-746.1999;
14. Irvin , III , IIIG.L., Dembrow V.D., Prudhomme D.L.: Clinical usefulness of an intraoperative “quick parathyroid hormone” assay. Surgery 114. 1019-1022.1993;
15. Carneiro D.M., Solorzano C.C., Nader M.C., et al: Comparison of intraoperative iPTH assay (QPTH) criteria in guiding parathyroidectomy: which criterion is the most accurate?. Surgery 134. 973-979.2003;
16. Barczynski M., Konturek A., Hubalewska-Dydejczyk A., et al: Evaluation of Halle, Miami, Rome, and Vienna intraoperative iPTH assay criteria in guiding minimally invasive parathyroidectomy. Langenbecks Arch Surg 394. 843-849.2009;
17. Yang G.P., Levine S., Weigel R.J.: A spike in parathyroid hormone during neck exploration may cause a false-negative intraoperative assay result. Arch Surg 136. 945-949.2001;
18. Lombardi C.P., Raffaelli M., Traini E., et al: Intraoperative PTH monitoring during parathyroidectomy: the need for stricter criteria to detect multiglandular disease. Langenbecks Arch Surg 393. 639-645.2008;
19. Gil-Cárdenas A., Gamino R., Reza A., et al: Is intraoperative parathyroid hormone assay mandatory for the success of targeted parathyroidectomy?. J Am Coll Surg 204. 286-290.2007;
20. Jacobson S.R., van Heerden J.A., Farley D.R., et al: Focused cervical exploration for primary hyperparathyroidism without intraoperative parathyroid hormone monitoring or use of the gamma probe. World J Surg 28. 1127-1131.2004;
21. Mihai R., Palazzo F.F., Gleeson F.V., et al: Minimally invasive parathyroidectomy without intraoperative parathyroid hormone monitoring in patients with primary hyperparathyroidism. Br J Surg 94. 42-47.2007;
22. Ollila D.W., Caudle A.S., Cance W.G., et al: Successful minimally invasive parathyroidectomy for primary hyperparathyroidism without using intraoperative parathyroid hormone assays. Am J Surg 191. 52-56.2006;
23. Pang T., Stalberg P., Sidhu S., et al: Minimally invasive parathyroidectomy using the lateral focused mini-incision technique without intraoperative parathyroid hormone monitoring. Br J Surg 94. 315-319.2007;
24. Stalberg P., Sidhu S., Sywak M., et al: Intraoperative parathyroid hormone measurement during minimally invasive parathyroidectomy: does it “value-add” to decision-making?. J Am Coll Surg 203. 1-6.2006;
25. Barczynski M., Konturek A., Cichon S., et al: Intraoperative parathyroid hormone assay improves outcomes of minimally invasive parathyroidectomy mainly in patients with a presumed solitary parathyroid adenoma and missing concordance of preoperative imaging. Clin Endocrinol (Oxf) 66. 878-885.2007;
26. Irvin , III , IIIG.L., Molinari A.S., Figueroa C., et al: Improved success rate in reoperative parathyroidectomy with intraoperative PTH assay. Ann Surg 229. 874-878.1999;
27. Bergson E.J., Sznyter L.A., Dubner S., et al: Sestamibi scans and intraoperative parathyroid hormone measurement in the treatment of primary hyperparathyroidism. Arch Otolaryngol Head Neck Surg 130. 87-91.2004;
28. van Heerden J.A., Grant C.S.: Surgical treatment of primary hyperparathyroidism: an institutional perspective. World J Surg 15. 688-692.1991;
29. Grant C.S., Thompson G., Farley D., et al: Primary hyperparathyroidism surgical management since the introduction of minimally invasive parathyroidectomy: Mayo Clinic experience. Arch Surg 140. 472-478.2005;
30. Irvin , III , IIIG.L., Carneiro D.M., Solorzano C.C.: Progress in the operative management of sporadic primary hyperparathyroidism over 34 years. Ann Surg 239. 704-708.2004;
31. Low R.A., Katz A.D.: Parathyroidectomy via bilateral cervical exploration: a retrospective review of 866 cases. Head Neck 20. 583-587.1998;